Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GOLGA2 pseudogene 4 (abbreviated as GOLGA2P4) is classified as a pseudogene and therefore does not code for a functional protein, receptor, enzyme, or therapeutic target. No physiological or biomedical roles have been established for GOLGA2P4, and there is no evidence that it participates in molecular pathways relevant to human disease or drug action[5]. The designation "pseudogene" indicates that GOLGA2P4 arose through gene duplication or retrotransposition, but accumulation of disabling mutations has rendered it noncoding and nonfunctional in typical cellular contexts[5]. No dataset, functional annotation, or disease association has been curated for GOLGA2P4 in authoritative genetic databases[5]. The functional GOLGA2 gene encodes Golgin A2 (GM130), a critical player in Golgi apparatus structure and function[1][2][3], but GOLGA2P4 does not produce the GM130 protein nor participate in Golgi-related molecular architecture.
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GOLGA2 pseudogene 4 (GOLGA2P4).